See what questions
a doctor would ask.
CoTherix Inc. has had it's new drug Ventavis approved by the FDA for use as an inhalant treatment for pulmonary arterial hypertension in patients with heart failure symptoms. Roughly 50,000 US people are believed to have the condition but only 15,000 have been diagnosed and are being treated.
Source: summary of medical news story as reported by Forbes
About: FDA approves new pulmonary arterial hypertension drug
Date: 29 December 2004
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City